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Abstract
In children with Duchenne muscular dystrophy, color vision losses have been related to dystrophin deletions downstream of exon 
30, which affect a dystrophin isoform, Dp260, present in the retina. To further evaluate visual function in DMD children, we 
measured spatial, temporal, and chromatic red-green and blue-yellow contrast sensitivity in two groups of DMD children with 
gene deletion downstream and upstream of exon 30. Psychophysical spatial contrast sensitivity was measured for low, middle, and 
high spatial frequencies with achromatic gratings and for low and middle frequencies with red-green and blue-yellow chromatic 
gratings. Temporal contrast sensitivity was also measured with achromatic stimuli. A reduction in sensitivity at all spatial luminance 
contrasts was found for the DMD patients with deletion downstream of exon 30. Similar results were found for temporal luminance 
contrast sensitivity. Red-green chromatic contrast sensitivity was reduced in DMD children with deletion downstream of exon 30, 
whereas blue-yellow chromatic contrast sensitivity showed no significant differences. We conclude that visual function is impaired 
in DMD children. Furthermore, we report a genotype-phenotype relationship because the visual impairment occurred in children 
with deletion downstream but not upstream of exon 30, affecting the retinal isoform of dystrophin Dp260. Keywords: Duchenne 
muscular dystrophy, color vision, contrast sensitivity, temporal and spatial visual function, psychophysics.
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Introduction
Duchenne muscular dystrophy (DMD) is the most 
common dystrophy disease, which is caused by an 
alteration in dystrophin. Duchenne muscular dystrophy 
affects 1 in every 3500 males (Matsuo, 1996; Nobile, 
Marchi, Nigro, Roberts, & Danieli, 1997; O’Brien & 
Kunkel, 2001). The dystrophin gene is composed of 79 
exons with approximately 2500 kilobases (kb) of DNA 
(Nobile et al., 1997) and is located in region 21 of the 
short arm of the X-chromosome. The defective expression 
of muscle dystrophin, an X-linked genetic disease, 
is characterized by progressive muscle degeneration, 
leading to death (Koenig, Monaco, & Kunkel, 1988).
Genetic alterations may differ in DMD patients. Gene 
deletions occur with a frequency of 65%; duplications 
occur with a frequency of 5%; and point mutations or 
deletions/duplications that occur on a small scale occur 
in 30% (Sitnik et al., 1997; Verbovaia & Razin, 1997). 
Severely affected DMD patients might have deletions 
in the regions of dystrophin that make connections with 
other proteins, such as the N- and C-terminal regions. 
The less severe cases may have up to 50% deletions of 
the total size of the gene. If these deletions occur in the 
central region and do not affect the rod-form region of 
dystrophin, then the connection sites with other proteins, 
such as actin, may be preserved (Zatz, 2002).
One of the aspects of phenotypes of DMD and 
its milder allelic variant Becker muscular dystrophy 
(BMD) are alterations in the electric activity of the 
retina measured by full-field electroretinogram (ERG). 
These alterations have been found in different studies 
and vary from 50% to 88% of cases (Blake & Kroger, 
2000; Girlanda et al., 1997; Mehler, 2000). The scotopic 
ERG obtained in the patients with DMD is characterized 
by a large amplitude reduction that produces a complete 
suppression of the b-wave, resulting in a negative ERG 
(i.e., a reduction of the b/a-wave ratio to values below 
1; Ino-ue et al., 1997; Pillers, 1999). This suggests 
dysfunction of the response capacity of ON bipolar 
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rod pathway cells (Pillers et al., 1999) and functionally 
identifies the outer plexiform layer as the main site of 
dystrophin in the retina (D’Souza et al., 1995; Fitzgerald 
et al., 1999; Fitzgerald, Cibis, Giambrone, & Harris, 
1994; Pillers et al., 1993; Yang et al., 2001). A phenotype-
genotype correlation was evident in these previous 
studies, in which reductions were associated with 
deletion downstream of exon 30. Children with deletion 
upstream of exon 30 showed a normal ERG. The ERG 
of cone responses under photopic stimulation revealed 
a lower amplitude and increased latency of the b-wave 
(Fitzgerald et al., 1994; Pillers et al., 1999; Schmitz & 
Drenckhahn, 1997), although these alterations were not 
as evident as the scotopic ERG changes.
Sigesmund et al. (1994) studied vision in 26 
patients with DMD and did not find alterations in 
refraction, ocular motility, or Snellen’s visual acuity. Of 
these patients, 21 were evaluated with the Farsnworth-
Munsell 100Hue and Ishihara color vision tests, and 
only one showed a red-green defect. The usual clinical 
measure for evaluating human spatial vision is visual 
acuity, which is the spatial resolution capacity for a high-
contrast stimulus. Sigesmund et al. (1994) classified the 
spatial vision of their 26 patients as normal, based only 
on their Snellen visual acuity.
In a recent study, which considered the genotype-
phenotype association found in the ERG evaluation, 
we measured color discrimination in DMD children 
Author Year Subject Function Methods Results
 
Emery, AEH et al.,
 
1980
 
16 DMD* 
Children
 
Color Vision
 
Ishihara plates
 
Normal color vision
Sigesmund, DA et al., 1994 21 DMD Children Visual acuity 
Color Vision
Ishihara plates AO-
H-R-R plates
Normal visual acuity and 
color vision
De Becker, I et al., 1994 15 DMD Children Visual Acuity and 
retina physiology
Snellen Chart and 
full-field ERG
Normal Visual Acuity and 
reduced ERG amplitude and 
implicit time
Pillers, DA et al., 1995 mdx& Cv3 mouse retina physiology full-field ERG$ Negative ERG
Kameia, S et al., 1997 dystrophin exon 52 
knock-out mice
retina physiology full-field ERG Greather a-wave aplitude and 
longer implicit time
Pascual, SIP et al., 1998 DMD Children retina physiology full-field ERG Reduction in the B/A ratio
Girlanda, P et al., 1997 18 DMD and 18 
BMD# children
retina physiology full-field ERG flash 
VEP%
Both VEP and ERG 
amplitude and implicit time 
altered
Fitzgerald, K et al., 1997 female DMD 
carrier
retina physiology full-field ERG Reduction in B/A ratio 
reduction in ON amplitude
Benoff, K et al., 2001 8 DMD Children Visual Pathway 
physiology
Chessboard VEP Reduction in the ON-
Magnocellular Pathway
Green, DG et al., 2004 8 mdx retinas phototransduction 
retina physiology
full-field ERG normal transduction 
abnormal ERG
Costa, MF et al., 2007 70 DMD Children Color Vision Color 
discrimination
Red-green color defect 
in DMD with deletion 
downstream exon 30
Galindo, BER et al., 2009 14 DMD patients Visual acuity and 
Visual fields
30º Computerized 
Perimetry and 
Snellen Chart
Low and middle visual 
acuity reduction in 50 % and 
normal fields
Table 1. Visual pathway physiology and visual function in DMD patients
* DMD - Duchenne Muscular Dystrophy, & mdx - dystrophyn genetic model, # BMD - Becker Muscular Dystrophy, $ ERG - 
Electroretinogram, % VEP - Visual Evoked Potentials
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grouped according to their gene deletion site (i.e., 
downstream of exon 30 [dDMD] or upstream of exon 
30 [uDMD]; Costa, Oliveira, Feitosa-Santana, Zatz, 
& Ventura, 2007). A red-green color vision defect was 
found in children with dDMD. The uDMD children had 
normal color vision. These results led us to conclude that 
the impairment in color vision in these DMD children 
had at least a partial retinal origin.
Vision in DMD patients has not been extensively 
examined, and very few studies are available. Table 1 
summarizes the studies we could find in the literature.
Little attention has been dedicated to the examination 
of visual function in patients with DMD. We had previously 
found evident color perception impairment in subjects 
with dDMD. The present study further investigated visual 
function in DMD. Psychophysical measurements of 
spatial and temporal visual processing were conducted by 
measuring contrast sensitivity for both spatial (luminance 
and chromatic) and temporal modulations.
Methods
Subjects
The DMD group was composed of 60 boys aged 9 to 
21 years (mean, 14.2 years, standard deviation [SD], 4.1 
years). They were referred from the Brazilian Muscular 
Dystrophy Association (ABDIM) in São Paulo. The 
control group was composed of 24 healthy boys aged 10 
to 23 years (mean= 15.4 years; SD= 3.9 years) with no 
ophthalmological or systemic diseases that could affect the 
visual system. All subjects underwent ophthalmological 
examination and had normal eye fundi and visual acuity. 
The number of subjects tested for each visual function 
varied because the contrast sensitivity tests were 
performed on different days to avoid fatigue, and not all 
subjects could return for the second session. Luminance 
spatial contrast sensitivity was measured in 57 Duchenne 
patients and 24 controls. Luminance temporal contrast 
sensitivity was measured in 32 Duchenne patients (i.e., 
22 dDMD and 10 uDMD) and 24 controls. Chromatic 
spatial contrast sensitivity was measured in 18 Duchenne 
patients (10 dDMD and 8 uDMD) and seven controls.
Genetic analysis, aimed at identifying the possible 
deletion or duplication sites in the dystrophin gene, 
was performed at the Center for Human Genome 
Studies, Institute of Biosciences, University of São 
Paulo. All procedures were performed under the tenets 
of the Declaration of Helsinki and were approved by 
the Ethical Committee of the University Hospital, 
University of São Paulo (CEP-HU/USP 642/06). Signed 
informed consent was obtained from the subjects after 
explanation of the nature of the study.
Stimuli and procedure
Temporal and spatial luminance contrast sensitivity 
was measured psychophysically using the PSYCHO 
software for Windows, version 2.36 (Cambridge 
Research Systems). The stimuli were presented on 
a 19 inch Sony Trinitron monitor (GFD-420) with a 
Cambridge Research VSG 2/4 graphic card, a sweeping 
frequency of 100 Hz, and a resolution of 800 ´ 600 
dots per inch (dpi). For the spatial luminance contrast 
sensitivity measures, the stimuli were black and white 
sinusoidal gratings subtending 4° of the visual angle at 1 
m. We tested the following spatial frequencies: 0.5, 1.0, 
2.0, 5.3, 9.7, and 19.4 cycles per degree (cpd). The mean 
luminance of the stimulus was 34.4 cd/m2, measured 
using an Optical OP200-E photometer (Cambridge 
Research Systems). The stimulus was presented on 
a gray background of the same mean luminance. 
Measurements were made monocularly in one randomly 
selected eye. For more details on the methods, see 
Ventura et al. (2005a, b) and Canto-Pereira et al. (2005).
To determine the contrast sensitivity function, we 
used the psychophysical method of adjustments, in which 
contrast thresholds were obtained by varying contrast at 
each spatial frequency. The subject was instructed to 
inform the examiner when he stopped seeing the stimulus 
and when the stimulus was back. Because some DMD 
subjects had motor problems in the upper limbs, the 
examiner controlled the response box (CB3; Cambridge 
Research Systems), which had two buttons: one was used 
to adjust the level of the contrast, and the other was used 
to record the response. At the beginning of the test, the 
sinusoidal grating was at the maximum contrast. The 
examiner then reduced the contrast level in 1% steps from 
100% to 0% until the subject was unable to discriminate 
the stimulus from the uniform background. The contrast 
level was then further reduced by approximately 5%, 
and then the examiner increased the contrast level in 1% 
steps until the subject informed the experimenter that 
he saw the stimulus again. The procedure was repeated 
three times at each spatial frequency. The presentation of 
spatial frequencies was randomized by the software.
For the temporal luminance contrast sensitivity 
measure, we used sinusoidal modulation between 
black and white with a 2.7° radius Gaussian function 
superimposed and a cutoff for the average luminance at 1 
SD. The mean luminance level was the same as that used 
for the spatial contrast measure. We used the following 
temporal frequencies: 1.0, 2.0, 10.0, 20.0, and 33.0 Hz. 
The testing procedure was analogous to that of 
the spatial contrast sensitivity determination, with the 
exception that the subject had to inform the examiner 
whether the stimulus ceased or started to flicker, depending 
on the direction of change in temporal frequency.
Chromatic contrast sensitivity was determined 
with counterphase-modulated red-green or blue-yellow 
sinusoidal gratings with a 4° ´  4° visual angle at the following 
spatial frequencies: 0.2, 0.3, 0.5, 0.7, 1.2, and 2.0 cpd. 
Equiluminance adjustments were made for the red–green 
stimuli and blue–yellow stimuli at each spatial frequency 
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using a heterochromatic flicker photometry procedure at 20 
Hz. All measurements were performed monocularly in the 
same eye that was selected for luminance contrast sensitivity. 
The chromaticities of the stimuli in x, y coordinates of the 
1931 CIE color space were the following: D6500: 0.296, 
0.31; green: 0.225, 0.333; red: 0.356, 0.275; blue: 0.254, 
0.2; yellow: 0.386, 0.53. The red–green and blue–yellow 
axes were orthogonal and corresponded, respectively, to 
L–M-isolating and S-isolating stimuli (De Valois, De Valois, 
Switkes, & Mahon, 1997). 
Results
A full descriptive analysis was performed for the 
data. The normality of distribution was checked using the 
Komolgorov-Smirnov test. Because the results were close 
to normality, one-way analysis of variance (ANOVA) 
was used to assess the mean differences, followed by the 
Fisher Least Significant Difference (LSD) post hoc test 
when significant differences were observed.
Table 2 shows a summary of the results found for 
the DMD groups compared with the controls for each 
visual function tested.
Luminance contrast sensitivity
Spatial modulation
The average (± 1 SD) luminance spatial contrast 
sensitivity as a function of spatial frequency is shown in 
Figure 1 for each group. The luminance spatial contrast 
 DMD Upstr 30# DMD Downstr 30$
Luminance Contrast Senstivity
Spatial Modulation (cpd)
0.5 NS* p< 0.001
1.0 NS p< 0.001
2.0 NS p< 0.001
5.3 NS p< 0.001
9.7 NS p< 0.001
19.4 NS p< 0.001
Temporal Modulation (Hz)
1.0 NS p< 0.001
2.0 NS p< 0.001
10.0 NS p< 0.001
20.0 NS p= 0.011
33.0 NS NS
Chromatic Contrast Senstivity
Red-green Modulation (cpd)
0.2 NS p= 0.002
0.3 NS p= 0.003
0.5 NS p= 0.002
0.7 NS p< 0.001
1.2 NS p< 0.001
2.0 NS p< 0.001
Blue-Yellow Modulation (cpd)
0.2 NS NS
0.3 NS NS
0.5 NS NS
0.7 NS NS
1.2 NS p= 0.004
2.0 NS p= 0.002
Table 2.  Summary of the Contrast Sensitivity Results for DMD Children Compared to Control Subjects
* NS = Not Statisticaly significant # Upstr = Deletion Upstream exon 30 $ Downstr = Deletion Downstream exon 30
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sensitivity functions (CSFs) exhibit normal bandpass 
shapes known for sinusoidal gratings in all groups, but 
the controls’ thresholds were higher than the patients’ 
thresholds (Figure 1). A statistically significant difference 
between the results from control subjects and dDMD 
subjects was found for the low and lower-middle spatial 
frequencies (0.5 cpd, F = 17.31, p < .001; 1.0 cpd, F = 
26.22, p < .001; 2.0 cpd, F = 30.88, p < .001). For the 
higher-middle spatial frequency (5.3 cpd, F = 20.72, p < 
.001) and high spatial frequencies (9.7 cpd, F = 21.42, p < 
.001; 19.4 cpd, F = 35.89, p < .001), significant differences 
were found between the controls and the dDMD group.
Temporal modulation
Luminance temporal contrast sensitivity was measured 
in 32 Duchenne patients (i.e., 22 dDMD and 10 uDMD) 
and 24 age-matched control subjects. The temporal 
CSFs exhibited bandpass shapes in all groups (Figure 2). 
Significant differences were found between groups at all 
temporal frequencies, with the exception on 33 Hz (p > .05). 
Figure 1. Spatial luminance contrast sensitivity function 
in controls and DMD children. A sensitivity reduction of 
approximately 0.5 log unit was found in the DMD children 
with deletion downstream of exon 30 for all spatial frequencies.
	  
Figure 2. Temporal luminance contrast sensitivity function in 
controls and DMD children. Sensitivity reduction was found 
in the DMD children with deletion downstream of exon 30 at 
all temporal frequencies, with the exception of 33 Hz.
	  
For 1 and 2 Hz, the control subjects and uDMD patients 
differed from the dDMD patients (1 Hz, F = 9.87, p < .001; 
2 Hz, F = 6.86, p < .001). For 10 and 20 Hz, control subjects 
differed only from dDMD subjects (F = 8.28, p < .001, and 
F = 5.03, p = .011, respectively). For 33 Hz, controls and 
both groups of Duchenne patients had similar thresholds.
Chromatic contrast sensitivity
In the red-green spatial CSF, control subjects and 
uDMD patients had higher contrast sensitivity values 
compared with the dDMD group for all spatial frequencies 
(0.2 cpd, F = 9.43, p = .002; 0.3 cpd, F = 7.27, p = .003; 
0.5 cpd, F = 8.96, p = .002; 0.7 cpd, F = 22.54, p < .001; 
1.2 cpd, F = 10.53, p < .001; 2 cpd, F = 19.09, p < .001). 
Figure 3. Red-green (upper panel) and blue-yellow (lower 
panel) chromatic contrast sensitivity function in controls and 
DMD children. Sensitivity reduction was found for red-green 
contrast in DMD children with deletion downstream of exon 
30 compared with controls at all spatial frequencies. Blue-
yellow contrast showed a reduction in sensitivity only for the 
two highest spatial frequencies tested.
	  
Discrepant results were found for the blue-yellow 
spatial CSF compared with the results of the red-green CSF. 
Significant differences were found in the control group and 
uDMD group compared with the dDMD only for the two 
higher spatial frequencies (1.2 cpd, F = 6.99, p = .004; 2.0 
cpd, F = 8.21, p = .002). The red-green and blue-yellow 
chromatic contrast sensitivity results are shown in Figure 3.
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Discussion
The present study revealed visual losses in dDMD 
patients for the detection of spatial luminance and 
chromatic sinusoidal gratings and for the processing 
of temporally modulated stimuli. The visual system in 
DMD patients has been studied more intensely in the 
past two decades, mainly using electrophysiological 
methods (Ino-ue et al., 1997; Fitzgerald et al., 1999; 
Pillers et al., 1999). The few studies that investigated 
visual function behaviorally did not find alterations in 
color vision or visual acuity (Sigesmund et al. 1994). In 
contrast with these results, our previous work found that 
a red-green color vision defect existed in DMD children 
with dDMD (Costa et al., 2007; Costa, Oliveira, 
Feitosa-Santana, Zatz, & Ventura, 2008). This result 
was consistent with ERG studies that demonstrated 
impairment associated with this genotype (Fitzgerald et 
al., 1999; Pillers et al., 1993, 1999). 
To our knowledge, the present study shows the first 
contrast sensitivity data obtained in patients with DMD. 
The only information available in the literature about 
spatial vision in subjects with DMD is from the work of 
Sigesmund et al. (1994), in which Snellen visual acuity 
was evaluated in 20 DMD children who were found to 
have normal vision.
The early studies on vision in DMD children 
concluded that they had normal vision, despite abnormal 
ERG findings (Sigesmund et al., 1994). However, we 
showed in our previous work and in the present study 
that the dDMD subgroup of children had chromatic and 
spatial vision impairment, and these impairments were 
related to a specific visual pathway, as explained below.
Spatial and temporal perception
The spatial luminance contrast sensitivity results 
showed a reduction in sensitivity in the dDMD subjects 
compared with control and uDMD subjects. The 
reduction observed occurred at all spatial frequencies 
tested, suggesting a decrease in the perceptual ability to 
visually detect spatial changes of luminance for a wide 
range of size elements.
The deletion that occurs downstream of exon 30 
impairs Dp260 function and the existence of the phenotype-
genotype relationship strongly supports the hypothesis that 
the reduction in CSF could be related to damage of the 
visual information processing pathways at the retinal level.
The significant reduction in spatial contrast sensitivity 
of almost one log unit compared with the control group 
is fundamentally important for clinical application. 
Unfortunately, the clinical evaluation of spatial visual 
function is limited to the measurement of visual acuity. 
For this reason, DMD patients were regarded as having 
normal vision by Sigesmund et al. (1994).
In the present work, contrast sensitivity was also 
tested for temporally modulated stimuli. We found a 
reduction in the detection of luminance contrasts for the 
two lowest temporal modulations (i.e., 1 and 2 Hz). The 
reduction affected visual function in dDMD subjects, 
suggesting a phenotype-genotype relationship. The 
reduction in the lowest temporal frequencies also has 
important physiological implications related to the visual 
pathways, which is discussed in the following section.
No significant difference was found for the highest 
temporal frequency tested (i.e., 33 Hz). At this temporal 
frequency, the ability to discriminate differences in contrast 
was reduced in all groups, and showing differences 
between groups was not possible. Nevertheless, the similar 
luminance detection found for the 20 Hz modulations 
indicates that the information processing for high temporal 
frequencies was preserved in dDMD children.
Interesting results were obtained with regard to 
spatial chromatic CSF. For red-green contrast, the 
sensitivity of dDMD children was significantly reduced 
compared with controls and uDMD children. However, 
for the blue-yellow color contrast, the difference was 
only found for the two highest spatial frequencies 
tested, with the dDMD children being the most affected 
group. This result is consistent with our previous study 
of color discrimination (Costa et al., 2007, 2008), in 
which we found red-green color vision impairment in 
dDMD children and normal blue-yellow discrimination.
These results suggest that the dystrophy isoform 
(Dp260) plays an important role in retina physiology 
(Ino-ue et al., 1997; Pillers, 1999), and impairment in 
the gene structure caused by deletions affects many 
visual functions (Costa et al., 2007, 2008).
Possible visual pathways implications
Visual information is conducted to the visual 
areas of the brain via three main visual pathways: (i) 
magnocellular pathway, related to processing of high 
temporal frequencies and low spatial frequencies, (ii) 
parvocellular pathway, related to low temporal and 
high spatial frequencies and red-green color processing, 
and (iii) koniocellular pathway, related to blue-yellow 
color vision, low to middle spatial frequencies, and 
middle to high temporal frequencies (for review, see 
Xu et al., 2001). The battery of spatial and temporal 
contrast sensitivity tests that we used supports the 
hypothesis that the parvocellular pathway is the most 
affected visual pathway in DMD. With regard to 
spatial contrast sensitivity, we found impairment at 
all spatial frequencies, reflecting both magno- and 
parvocellular pathway impairment. However, temporal 
contrast sensitivity showed a reduction for the low 
temporal frequencies (i.e., 1 and 2 Hz), indicating 
selective parvocellular impairment. In the chromatic 
contrast sensitivity experiments, selective parvocellular 
impairment was also found. Red-green color information 
is processed by the parvocellular pathway, and blue-
yellow information is processed by the koniocellular 
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pathway. Our chromatic contrast sensitivity results 
showed red-green impairment but quasi normal blue-
yellow color contrast, in which worse discrimination 
was observed only for the highest spatial frequencies, 
reinforcing the conclusion of preferential parvocellular 
pathway impairment in dDMD children.
Previous studies in DMD children that used 
electrophysiological methods found impairment 
in the functions processed by the magnocellular 
pathways (Benoff et al., 2001). They measured VEPs 
to checkerboard stimuli of different spatial frequencies 
in black-gray and white-gray modulation to isolate the 
ON- and OFF-pathway responses. They found a large 
reduction in magnocellular ON-pathway luminance 
processing in dDMD children. Our observation of 
reduced contrast sensitivity at low spatial frequencies 
is consistent with this previous study and supports 
the possible existence of magnocellular impairment 
in dDMD children. One possibility is that spatial 
processing mediated by the magnocellular pathway 
could be impaired despite normal or close to normal 
temporal processing.
No differences were found between the two DMD 
groups and controls for blue-yellow contrast sensitivity. 
This absence of impairment confirms our previous 
results on chromatic discrimination, showing that dDMD 
children had selective red-green impairment and normal 
discrimination along the blue-yellow color confusion axis.
The mechanisms that underlie this color vision loss 
in DMD are unknown. Some possible explanations may 
explain why deletion downstream of exon 30 had greater 
effects in parvo- and magnocellular visual pathway 
function despite normal visual function processed by 
the koniocellular pathway. The participation of S-cones 
in the detection of the luminance levels of stimuli 
with spatial variations is practically null (Kaiser & 
Boynton, 1996); therefore, normal S-cone function can 
coexist with a generalized reduction in spatial contrast 
sensitivity function, similar to the present observations. 
Dystrophin is present in all three cone types and in rods, 
which would lead to the expectation that a deletion in its 
gene would result in impairment for all visual functions 
tested. However, our results revealed a different picture. 
Blue-yellow contrast sensitivity and the response to 
high temporal frequencies were unimpaired.
The understanding of S-cone color processing in 
the retina is limited, and the existence of the S-OFF 
cone pathway in the retina is still not established (Dacey 
& Packer, 2003; Lee, 2004; Joselevitch, 2008). We may 
attempt to understand why blue system sensitivity is 
spared in DMD by examining the morphology of the 
connections between S-cones and ON bipolar cells. 
A study by Calkins (2001) showed that ON bipolar 
cells make contact with S-cones in two different ways: 
characteristic ON-type invaginating contacts and other 
numerous semi-invaginating contacts with S-cones. 
Because dystrophin would affect invaginating contacts 
because of its location near the synaptic ribbon, 
it might not influence the physiology of these ON 
bipolar cells, considering that most of their contacts 
with S-cones are located close to, but not directly in, 
the invaginating region. This could explain why DMD 
children had normal blue-yellow contrast sensitivity. 
The normal temporal contrast sensitivity for higher 
spatial frequencies could also be attributable to the 
specificity of koniocellular pathway synapses. Konio 
cells have three subgroups: K1 and K2 related to spatial 
and temporal information processing and K3 related 
to color processing (Xu et al., 2001). The K1 and K2 
subgroups could maintain sufficient information of 
temporal processing, supporting normal temporal 
contrast sensitivity for middle and higher frequencies.
Concluding remarks
In recent years, studies have shown that dDMD 
children have abnormal ERG function. We showed that 
they also have impairment in spatial, temporal, and 
chromatic visual function mediated by the parvocellular 
and magnocellular pathways, with normal blue-yellow 
chromatic visual function. The phenotype-genotype 
relationship suggests that the early stages of sensory 
inputs of visual information are damaged, and the 
visual losses could be at least partially attributable to 
impairment in the Dp260 retinal isoform of dystrophin. 
The selective losses in the parvocellular pathway and 
magnocellular pathway, although less evident, should 
be investigated further. Analyses of the anatomical 
and physiological properties of the retina that could 
be related to these losses may lead to future studies on 
retinal structure and physiology.
Children with DMD also have mental impairment, 
reflected in borderline or reduced scores in the full intelligence 
quotient and visuospatial tests (Wicksell, Kihlgren, Melin, 
& Eeg-Olofsson, 2004), visuomotor impairment (Marsh, 
1972; Mehler, 2000), a reduction in verbal ability (Bresolin 
et al., 1994), and impairment in reading ability (Billard, 
Gillet, Barthez, Hommet, & Bertrand, 1998).
Improvements in respiratory management 
and pharmacological drugs have increased the life 
expectancy of DMD children by almost a decade. 
Understanding their sensory, perceptual, and cognitive 
capacities will became crucial for increasing their 
quality of life through the support of more efficient 
rehabilitation procedures.
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